Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

February 18, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Parkinson's Disease (PD)
Interventions
DRUG

ABBV-951

Solution for continuous subcutaneous infusion (CSCI).

Trial Locations (52)

2145

Westmead Hospital /ID# 218418, Westmead

2170

Liverpool Hospital /ID# 221693, Liverpool

3050

The Royal Melbourne Hospital /ID# 218419, Parkville

4215

Gold coast University Hospital /ID# 221694, Southport

5000

Royal Adelaide Hospital /ID# 218417, Adelaide

11042

Northwell Health /ID# 218600, Lake Success

19107

Thomas Jefferson University Hospital /ID# 218594, Philadelphia

20007

Georgetown University Hospital /ID# 218599, Washington D.C.

29615

Prisma Health-Upstate /ID# 217803, Greenville

32174

Neurology Associates Ormond Beach /ID# 217800, Ormond Beach

33613

University of South Florida- Neuroscience Institute /ID# 218481, Tampa

33980

Parkinson's Disease Treatment Center of Southwest Florida /ID# 222679, Port Charlotte

34470

Renstar Medical Research /ID# 217837, Ocala

35233

University of Alabama at Birmingham - Main /ID# 217814, Birmingham

60612

Rush University Medical Center /ID# 217807, Chicago

60637

University of Chicago Medical /ID# 218611, Chicago

63110

Washington University-School of Medicine /ID# 217723, St Louis

64111

St. Luke's Hosp. of Kansas City /ID# 218604, Kansas City

77030

Baylor College of Medicine /ID# 217728, Houston

77429

Houston Pulmonary Sleep and Allergy Associates /ID# 218473, Cypress

80045

University of Colorado Hospital /ID# 218486, Aurora

84132

University of Utah Health Care /ID# 218597, Salt Lake City

85004

Xenoscience, Inc /ID# 222515, Phoenix

90048

Duplicate_Cedars-Sinai Medical Center-West Hollywood /ID# 218607, West Hollywood

90095

University of California, Los Angeles /ID# 218460, Los Angeles

92037

University of California, San /ID# 218595, San Diego

92354

Loma Linda University Medical /ID# 217724, Loma Linda

93710

Neuro Pain Medical Center /ID# 217720, Fresno

36604-3302

University of South Alabama /ID# 218467, Mobile

85013-4407

Muhammad Ali Parkinson Center /ID# 218609, Phoenix

85258-4582

Movement Disorders Center of Arizona /ID# 218471, Scottsdale

91105-3149

SC3 Research Group - Pasadena /ID# 223018, Pasadena

80301-1880

Alpine Clinical Research Center /ID# 218461, Boulder

80210-7009

Denver Neurological Research, LLC /ID# 217811, Denver

80113-2736

CenExel Rocky Mountain Clinical Research, LLC /ID# 217731, Englewood

33176-2148

Visionary Investigators Network - Miami /ID# 217726, Miami

33407-3209

Premiere Research Institute - Palm Beach /ID# 218743, West Palm Beach

02135-2907

St Elizabeth's Medical Center - Brighton /ID# 223082, Brighton

08648-2300

Global Neurosciences Institute /ID# 218472, Lawrenceville

27612-8106

M3 Wake Research Inc. /ID# 218482, Raleigh

43054-8167

The Orthopedic Foundation /ID# 218608, New Albany

74136-6378

The Movement Disorder Clinic of Oklahoma /ID# 218580, Tulsa

97232-2003

Legacy Medical Group - Neurology /ID# 217804, Portland

19104-5502

University of Pennsylvania /ID# 218605, Philadelphia

29935-2029

Coastal Neurology /ID# 222893, Port Royal

37067-5914

KCA Neurology - Franklin /ID# 222811, Franklin

37232-0011

Vanderbilt University Medical Center /ID# 217722, Nashville

78701-4082

St. David's Healthcare Partnership, L.P., LLP /ID# 248148, Austin

78628-4126

Texas Movement Disorder Specialists /ID# 218610, Georgetown

23229-4913

Neurological Associates - Forest Ave /ID# 218458, Richmond

99202-1342

Inland Northwest Research /ID# 222520, Spokane

53226-3522

Duplicate_Medical College of Wisconsin /ID# 217721, Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY